| Not Yet Recruiting | Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer NCT05521997 | Washington University School of Medicine | Phase 2 |
| Not Yet Recruiting | Uniting Trusted Community Messengers to Improve Access to Cervical Cancer Screening in Rural North Carolina NCT07294066 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Recruiting | Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda NCT07276360 | Uganda Cancer Institute | Phase 2 |
| Recruiting | Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV NCT07428330 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Recruiting | Hyaluronic Acid-based Gel Spacers in Gynecologic Malignancies NCT07292818 | UNC Lineberger Comprehensive Cancer Center | Phase 1 |
| Not Yet Recruiting | Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing Chemoradiation NCT07245381 | Dr. Itay GoorAryeh | Phase 1 / Phase 2 |
| Not Yet Recruiting | AssociatiNG Bevacizumab bEmarituzumab for GynecoLogIcal CAncer NCT07146919 | Centre Leon Berard | Phase 1 / Phase 2 |
| Not Yet Recruiting | Ultrasound Training Program for Gynecologic Cancer Staging in Residents NCT07028229 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | N/A |
| Recruiting | Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study NCT07435623 | Tata Memorial Hospital | — |
| Recruiting | Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women NCT06904365 | Washington University School of Medicine | — |
| Completed | GYNecologic Cancer-Related COGnitive Impairment NCT06662435 | Northwestern University | N/A |
| Not Yet Recruiting | Evaluation of the Diagnostic and Prognostic Value of Immunohistochemical Markers in Precancerous Lesions of th NCT06852157 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | N/A |
| Enrolling By Invitation | Evaluation of AK104 (Cadonilimab) Combined with Chemotherapy for Recurrent or Metastatic Small Cell Neuroendoc NCT06810895 | Ding Ma | — |
| Recruiting | Minimally Invasive Simple Hysterectomy in Low Risk Cervical Cancer NCT06416748 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | N/A |
| Recruiting | Prevalence of Abnormal Pap Smear NCT06641531 | Sohag University | — |
| Completed | Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya NCT06263582 | UNC Lineberger Comprehensive Cancer Center | Phase 1 |
| Not Yet Recruiting | A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors NCT06383507 | Zhejiang University | Phase 1 |
| Recruiting | HPV Self-sampling for Women Who do Not Attend Cervical Cancer Screening Programme NCT06371118 | Universidade do Porto | N/A |
| Recruiting | The Gynecological Cancer Associated Thrombosis (GynCAT) Study NCT06284343 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Completed | The Effect of Cervical Cancer Awareness Education Based on Mobile Application NCT06252012 | Kutahya Health Sciences University | N/A |
| Recruiting | Adjuvant Chemotherapy in cfHPV-DNA Plasma Positive Patients: A Biomarker In Locally Advanced Cervical Cancer NCT05764044 | Hospital do Coracao | Phase 3 |
| Recruiting | Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix) NCT06266338 | University of Texas Southwestern Medical Center | Phase 2 |
| Completed | Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya NCT06165614 | UNC Lineberger Comprehensive Cancer Center | Phase 1 |
| Recruiting | A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologi NCT06215950 | Chongqing Precision Biotech Co., Ltd | Phase 1 |
| Recruiting | MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adapta NCT06041555 | Hospices Civils de Lyon | — |
| Recruiting | A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumo NCT06010875 | Chongqing Precision Biotech Co., Ltd | Phase 1 |
| Recruiting | A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in NCT06022029 | OncoNano Medicine, Inc. | Phase 1 |
| Recruiting | Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS) NCT06116019 | Charite University, Berlin, Germany | — |
| Recruiting | Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment) NCT05743517 | Northwestern University | N/A |
| Recruiting | Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study. NCT07400809 | Tata Memorial Hospital | — |
| Active Not Recruiting | Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries NCT06002126 | Weill Medical College of Cornell University | N/A |
| Active Not Recruiting | Survival Monitoring in Russian Cancer Registries NCT06043947 | N.N. Petrov National Medical Research Center of Oncology | — |
| Completed | Evaluating Scaleup of an Adapted Breast Cancer Early Diagnosis Program in Rwanda NCT05364138 | Brigham and Women's Hospital | — |
| Recruiting | Prognostic Value of Conization and Negative HPV After Conization in AIS and Early Stage Cervical Cancer NCT06196190 | Rambam Health Care Campus | — |
| Active Not Recruiting | A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid NCT05864144 | Sensei Biotherapeutics, Inc. | Phase 1 / Phase 2 |
| Unknown | Adherence and Compliance to ERAS in Gynecological Surgery NCT05738902 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | — |
| Active Not Recruiting | Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSel NCT05996783 | Universiteit Antwerpen | N/A |
| Recruiting | Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN) NCT05855941 | Region Västerbotten | — |
| Recruiting | Screening Triage and Risk Stratification NCT05727228 | University of Aarhus | — |
| Completed | Prolonged Grief and Perception of Femininity in Gynecological Cancer Patients NCT05529303 | Kevser Pamuk | N/A |
| Recruiting | Plan of the Day Radiotherapy NCT05634681 | Oslo University Hospital | N/A |
| Active Not Recruiting | Validation of Artificial Intelligence as Decision Support System in VIA (PRESCRIP-TEC) NCT06452004 | University Medical Center Groningen | N/A |
| Completed | Prevention and Screening Towards Elimination of Cervical Cancer NCT05234112 | University Medical Center Groningen | N/A |
| Unknown | A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T NCT05468190 | Chongqing Precision Biotech Co., Ltd | Phase 1 |
| Recruiting | A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors NCT05518253 | Weijia Fang, MD | Phase 1 |
| Unknown | The Effect of the Motivational Interviewing Technique on Breast and Cervical Cancer Screenings NCT05353387 | Istanbul Saglik Bilimleri University | N/A |
| Active Not Recruiting | Phase II Study of AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the Cervix NCT05063916 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer NCT05102240 | Tata Memorial Hospital | — |
| Unknown | A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors NCT05420545 | Chongqing Precision Biotech Co., Ltd | Phase 1 |
| Terminated | Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET Imaging NCT04514692 | Stanford University | Phase 1 / Phase 2 |
| Completed | Relational Agents in Cervical Cancer Education (RACE) NCT06537687 | Radhika Gogoi | N/A |
| Terminated | Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer NCT04651127 | Sun Yat-sen University | Phase 1 / Phase 2 |
| Completed | Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locati NCT04357873 | UNICANCER | Phase 2 |
| Completed | Neoadjuvant Chemotherapy in Cervical Cancer NCT05384366 | Banaras Hindu University | Phase 3 |
| Completed | COL Immunotherapy Before Radiochimio + Ipilimumab NCT04256213 | ARCAGY/ GINECO GROUP | N/A |
| Completed | Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical Cancer NCT04405349 | Nykode Therapeutics ASA | Phase 2 |
| Completed | Impact of a Sexological Follow-up on the Sexual Function in Patients With Cervix or Vaginal Cancer Treated by NCT03956498 | Institut Claudius Regaud | N/A |
| Unknown | Validation of the Genetic Signature 354849 as a Prognostic Method NCT04067882 | National Institute of Cancerología | — |
| Unknown | Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer NCT04096911 | Buhai Wang | Phase 2 |
| Unknown | A Novel Functional Imaging Technique With FLT-PET/MRI For Staging, Response Assessment and Radiation Treatment NCT05355558 | National Cancer Centre, Singapore | N/A |
| Completed | The Effect of Logotherapy on Mental Health in Gynecological Cancer Patients NCT05246462 | Akdeniz University | N/A |
| Completed | Opioid Free Anaesthesia in Oncologic Gynaecological Surgery: Is There Any Benefit? NCT05448586 | Instituto de Investigación Hospital Universitario La Paz | — |
| Completed | Impact of HPV on a Cohort of Southern Italian Women: Epidemiological, Clinical, Morphological and Microbiologi NCT03959410 | University of Campania Luigi Vanvitelli | N/A |
| Completed | 18F-ASIS PET/CT Imaging of Tissue Factor Expression In Patients With Primary and Metastastic Cancer NCT03790423 | Rigshospitalet, Denmark | Phase 1 |
| Completed | Thiol Disulfide Balance in Cervix Cancer NCT04258553 | Muğla Sıtkı Koçman University | — |
| Completed | Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours NCT03518606 | UNICANCER | Phase 1 / Phase 2 |
| Completed | Honduras Liger Thermocoagulator Study NCT03510273 | PATH | N/A |
| Completed | Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial NCT03233412 | Barretos Cancer Hospital | Phase 2 |
| Terminated | A Study of Pembrolizumab And Platinum With Radiotherapy in Cervix Cancer NCT03144466 | Royal Marsden NHS Foundation Trust | Phase 1 |
| Completed | Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery NCT02997553 | Institut de Cancérologie de Lorraine | Phase 3 |
| Unknown | Chemotherapy and Pelvic Hypofractionated Radiation Followed by Surgery Cervical Cancer NCT03750539 | National Institute of Cancerología | N/A |
| Active Not Recruiting | Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer NCT03239626 | Samsung Medical Center | N/A |
| Completed | Postoperative Hypofractionated Intensity-modulated Radiation Therapy with Concurrent Chemotherapy in Cervical NCT03239613 | Samsung Medical Center | N/A |
| Completed | Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. NCT03245736 | Seagen Inc. | Phase 2 |
| Completed | Effectiveness of Care in Certified Cancer Centres in Germany NCT04334239 | Technische Universität Dresden | — |
| Unknown | Colposcopy and Dynamic Spectral Imaging (DSI) NCT04249856 | University of Aarhus | — |
| Completed | Carboplatin-cyclophosphamide Combined With Atezolizumab NCT02914470 | The Netherlands Cancer Institute | Phase 1 |
| Completed | Prospective Evaluation of Patients With Uterine Cervical Cancer in Brazilian Health Institutions - The EVITA I NCT02671071 | Latin American Cooperative Oncology Group | — |
| Completed | Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors NCT02552121 | Seagen Inc. | Phase 1 / Phase 2 |
| Completed | Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer NCT02379039 | Umeå University | — |
| Terminated | PET CT With HX4 in Cervix Cancer NCT02233387 | Maastricht Radiation Oncology | Phase 2 |
| Completed | Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures. NCT02221076 | Mauna Kea Technologies | N/A |
| Completed | 2D vs 3D Planning for High-Dose Rate (HDR) Gynecological Brachytherapy NCT02091050 | AC Camargo Cancer Center | Phase 2 |
| Completed | Prevention of HPV in the School Health Service NCT02280967 | Uppsala University | N/A |
| Active Not Recruiting | Predictive Clinical and Biological Parameters in Gynecological Cancer NCT01977274 | Institut Paoli-Calmettes | N/A |
| Completed | Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors NCT02001623 | Seagen Inc. | Phase 1 / Phase 2 |
| Unknown | HPV E6/E7 mRNA Versus HPV DNA as Triage for Cervical Cancer Screening NCT02116920 | Tata Memorial Hospital | — |
| Completed | Study of the Diagnostic Efficacy of "Real Time" Niris 1300e Optical Coherence Tomography (OCT) Imaging System NCT01766284 | Preventive Oncology International, Inc. | N/A |
| Terminated | Study of a Predictor for Cervix Cancer NCT01641484 | Centre Oscar Lambret | N/A |
| Active Not Recruiting | Cervix Hypoxia FAZA NCT01549730 | University Health Network, Toronto | N/A |
| Terminated | Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition NCT00571415 | Virginia Commonwealth University | — |
| Completed | Dosimetric Planning Study Comparing Intensity Modulated Radiotherapy (IMRT) and 4-field Radiotherapy for Defin NCT00981552 | Sunnybrook Health Sciences Centre | EARLY_Phase 1 |
| Completed | Optimized Magnetic Resonance Brachytherapy (MR BT) in Cervix Cancer NCT00938106 | University Health Network, Toronto | Phase 2 |
| Completed | The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients NCT00859768 | Netherlands Open University | N/A |
| Active Not Recruiting | Intra-Pelvic Organ Motion for Cervix Cancer Patient Using Imaging NCT00957450 | University Health Network, Toronto | — |
| Completed | Matrix Metalloproteinases and Human Papillomavirus in Dysplasias and Cancers of the Cervix NCT04072913 | University Hospital, Bordeaux | N/A |
| Terminated | Study of Tumour Response to Tirapazamine During Treatment of Cervical Cancer NCT00493376 | British Columbia Cancer Agency | — |
| Terminated | Phase II Study , Association of Cisplatine Topotecan and Cetuximab in Patients Whith Late or in Progress Epith NCT00518193 | ARCAGY/ GINECO GROUP | Phase 2 |
| Completed | Cancer Prevention and Treatment Among African American Older Adults: Treatment Trial NCT00509444 | Johns Hopkins Bloomberg School of Public Health | Phase 3 |
| Completed | Partnership for Healthy Seniors NCT00379743 | Johns Hopkins Bloomberg School of Public Health | N/A |
| Completed | Prediction of Clinical Response and Outcome in Uterine Cervix Cancer NCT01764217 | Maastricht Radiation Oncology | — |
| Completed | CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy NCT00122772 | International Atomic Energy Agency | Phase 3 |
| Completed | A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patie NCT00329589 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 1 |
| Terminated | Efficacy Study of Weekly Topotecan With Cisplatin in Advanced Stage or Recurrent Cervical Cancer NCT00322920 | University of Alabama at Birmingham | Phase 1 |
| Completed | Computed Tomotherapy (CT) and Magnetic Resonance Imaging (MRI) Fusion on Radiation Treatment Planning for Pati NCT00126841 | Alberta Health services | — |
| Completed | Megavoltage CT (MVCT) Imaging for Intracavitary Radiation Treatment in Cervix Cancer NCT00124423 | AHS Cancer Control Alberta | — |
| Completed | Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma NCT00165126 | Dana-Farber Cancer Institute | — |
| Completed | CAmpto-CISplatine Plus Radiotherapy in Advanced Cervix Cancer : Search of Tolerated Maximum Dose of Campto NCT00251888 | ARCAGY/ GINECO GROUP | Phase 1 |
| Unknown | Impact of Erythropoietin Administration During Definitive Cervix Cancer Radiotherapy on Treatment Outcome NCT00348738 | Medical University of Vienna | Phase 3 |
| Completed | High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix NCT00193830 | Tata Memorial Hospital | Phase 3 |
| Completed | Investigation of Cervix Tumor Oxygenation and Microvasculature Using Magnetic Resonance Techniques NCT00242034 | University Health Network, Toronto | N/A |